These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9393215)

  • 1. Screening for fragile X syndrome: a model for genetic disorders?
    Barnicoat A
    BMJ; 1997 Nov; 315(7117):1174-5. PubMed ID: 9393215
    [No Abstract]   [Full Text] [Related]  

  • 2. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 3. Should all pregnant women be offered carrier testing for fragile X syndrome?
    Finucane B
    Clin Obstet Gynecol; 1996 Dec; 39(4):772-82. PubMed ID: 8934029
    [No Abstract]   [Full Text] [Related]  

  • 4. Population based prenatal screening for the fragile X syndrome.
    Palomaki GE
    J Med Screen; 1994 Jan; 1(1):65-72. PubMed ID: 8790488
    [No Abstract]   [Full Text] [Related]  

  • 5. Case finding for the fragile X syndrome and its consequences.
    Turner G; Robinson H; Wake S; Laing S; Partington M
    BMJ; 1997 Nov; 315(7117):1223-6. PubMed ID: 9393231
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 7. Who should be offered genetic screening?
    Super M
    Postgrad Med J; 1993 Sep; 69(815):669-71. PubMed ID: 8255830
    [No Abstract]   [Full Text] [Related]  

  • 8. Population screening for fragile-X syndrome.
    Howard-Peebles PN; Maddalena A; Black SH; Schulman JD
    Lancet; 1993 Mar; 341(8847):770. PubMed ID: 8095683
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetics of Fragile X syndrome and its prevention].
    Boué J; Simon-Bouy B
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):273-9. PubMed ID: 9265049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening for fragile-X syndrome.
    Bundey S; Norman E
    Lancet; 1993 Mar; 341(8847):770. PubMed ID: 8095682
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive screening for fragile X syndrome.
    Lancet; 1986 Nov; 2(8517):1191-2. PubMed ID: 2877329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening for carriers of the fragile X syndrome; ethical exploration].
    de Jong A; de Wert G
    Ned Tijdschr Geneeskd; 2002 Mar; 146(13):611-5. PubMed ID: 11957380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it time for population-based prenatal screening for fragile-X?
    Palomaki GE; Haddow JE
    Lancet; 1993 Feb; 341(8841):373-4. PubMed ID: 8094139
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of fragile X syndrome by prenatal genetic diagnosis: advantages and controversial aspects].
    Tejada MI
    Rev Neurol; 2001 Oct; 33 Suppl 1():S14-9. PubMed ID: 12447813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and prevention of fragile-X syndrome. From the family study to the population screening programme: eighteen years of activity.
    Giovannucci Uzielli ML; Guarducci S; Cecconi A; Lenzi S; Ricci U; Balestrieri C; Petrocelli P; Lapi E
    Acta Genet Med Gemellol (Roma); 1996; 45(1-2):303-8. PubMed ID: 8872054
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA testing for fragile X syndrome in schools for learning difficulties.
    Slaney SF; Wilkie AO; Hirst MC; Charlton R; McKinley M; Pointon J; Christodoulou Z; Huson SM; Davies KE
    Arch Dis Child; 1995 Jan; 72(1):33-7. PubMed ID: 7717734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of prenatal population screening for fragile X syndrome.
    Hollingsworth B; Harris A
    Community Genet; 2005; 8(2):68-72. PubMed ID: 15925881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of prenatal carrier screening for fragile X syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.